C5AR1 and hepatocellular carcinoma: Together, these findings reveal a novel mechanism that LukS-PV as a bacterial toxin to inhibit HCC cell proliferation through epigenetic remodeling by targeting complement receptor C5aR1, laying the foundation of LukS-PV as a promising candidate for HCC treatment.